A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE4
EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year
- Status
- COMPLETED
- Phase
- N/A
Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants
- Status
- COMPLETED
- Phase
- PHASE4
An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)
- Status
- COMPLETED
- Phase
- N/A
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Trial of Tocilizumab in ALS Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
- Status
- COMPLETED
- Phase
- PHASE3
Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Short-Term Application of Tocilizumab Following Myocardial Infarction
- Status
- COMPLETED
- Phase
- NA
Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- N/A
Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
- Status
- COMPLETED
- Phase
- PHASE2
Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
- Status
- TERMINATED
- Phase
- PHASE4
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Comorbidities
- Status
- TERMINATED
- Phase
- PHASE1